Navigation Links
New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
Date:10/16/2007

NORTH BRUNSWICK, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Researchers testing a vaccine based on the live bacteria Listeria, in women with advanced cervical cancer found it to be safe. The Lovaxin C vaccine being developed by Advaxis Inc. (OTC Bulletin Board: ADXS), is intended to treat cervical cancer and head and neck cancers that result from the human papilloma virus (HPV). This marked the first time the vaccine had been treated in humans.

"Our long held belief that live Listeria vaccines are safe, even in end stage cancer patients, has been confirmed with the results from our recent Phase I/II study. We have just entered the age of safe bacterial therapies," said Dr. John Rothman, VP of Clinical Development.

The immune response that Listeria generates is called "cellular" immunity, the type needed to attack cancer. Listeria is one of the strongest stimulators of cellular immunity known. "By redirecting it against specific tumor types safely, we have created a new, and potentially very effective, class of cancer therapy," says Rothman.

Advaxis reported treating fifteen patients in three dosage groups with thirty-minute 250 ml infusions of Lovaxin C at three-week intervals. Patients were observed for a total of 111 days. With the exception of two women, all patients had had either stage IVb advanced, recurrent, or progressive cervical cancer.

Every patient experienced a flu-like syndrome in the three-to-twelve hours after dosing comprised of fever, chills, nausea, and occasional vomiting, which is consistent with immune stimulation. In the lower two doses, symptoms were well tolerated and resolved with the use of over the counter analgesics and antihistamines.

Although efficacy was not a primary focus of the trial, efficacy findings were obtained. Of the seven stable patients, three had reductions in their tumor mass subsequent to treatment. While most lesions increased in size, tumor reduction was seen in a number of lesions an
'/>"/>

SOURCE Advaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N.C., Nov. 25 Cempra Pharmaceutica..., president and chief executive officer, will pres...onference at 8:50 a.m. EST, December 1, 2009, at T...rnandes will provide an overview of the company,s ...reatment of drug-resistant pathogens including MRS...
(Date:11/25/2009)...if., Nov. 25 ChemoCentryx, Inc.,...rom the Company,s PROTECT-1 (the Prospective Rando...rial) of Traficet-EN(TM) (CCX282-B) in patients wi... clinical efficacy with a favorable safety and tol...e of clinical efficacy in the reduction of disease...
(Date:11/24/2009)...Nov. 24 Vermillion, Inc.... filed its Plan of Reorganization and Disclosure S... States Bankruptcy Court for the District of Delaw...ure Statement is presently scheduled for December ...he Plan scheduled for January 7, 2010. ,, The ...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice 13071 1Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice 13071 2The American Society of Hematology Announces New Honorific Award 51956 1The American Society of Hematology Announces New Honorific Award 51956 2Anthony Hess to Lead SAIC Health Solutions Business Unit 13070 1Anthony Hess to Lead SAIC Health Solutions Business Unit 13070 2Anthony Hess to Lead SAIC Health Solutions Business Unit 13070 3
...olymerase Inhibitor for Treatment of ...nadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announ...inical trial of ANA598, an investigational oral no...t of chronic hepatitis C virus (HCV) infection.,Th...olerability, and,pharmacokinetics following ascend...
... Clinical Immunology Societies opens,June 5, BOST...ans will convene to present new advances in unders...OCIS 2008, the 8th annual meeting of,the Federatio...-9 at the,Boston Marriott Copley Place., Conferen... for,conditions in which the human immune system p...
Other Medicine Technology:Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598 2Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598 3Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598 4Leading Immunologists Convene in Boston 2
(Date:11/27/2009)...lus low-emission vehicles may reduce future diseas...v. 27 (HealthDay News) -- Encouraging city dweller...offer much greater public health benefits than inc...hers have found. , The study compared the proje...and transport scenarios for London, England, and D...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrecipe...d-high Thanksgiving traffic numbers, with more tha..., providing a clear picture of what was served on ...Thanksgiving meal in 2009 weighed in at 2,225 calo...ear,s feast. According to the Allrecipes site, Sw...
(Date:11/27/2009)... Multi-purpose bilingual coloring books design...the business community to educate - inform parents...Safety issues to Dinosuars to ABC,S and a host of ...is, MO (PRWEB) November 27, 2009 -- Today’s ...to keep them busy any hour of the day, but one of ...
(Date:11/27/2009)... Three new interactive anatomy education apps ...s expand health sciences learning opportunities fo... Durham, NC (Vocus) November 27, 2009 -- Modality...), a division of Wolters Kluwer Health, today anno...ion apps on the App Store. Clemente’s Anatom...
(Date:11/26/2009)...ON, N.J., Nov. 27 The diabetes pop...er the next 25 years and annual medical spending o... from $113 billion today, according to a study pub...The National Changing Diabetes ® Program (NC...nalysis by a team from the University of Chicago. ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...oLite Offers Precision Laser Technology for Custom... Curves, LAS VEGAS, May 14 Syneron,s LipoLit...ed to liquefy and remove fat and tighten,skin, is ... the means to customize the liposuction procedure ...
...dy finds pressure readings rise, urges broader pub...May 14 (HealthDay News) -- Just a few hours of exp...ease blood pressure and harm blood vessel function...eart failure and stroke, the researchers said. , P...
...HAM, N.C., May 14 AlphaMed Press, publisher of th... The Oncologist, has,promoted George Kendall Vice ...ogo: http://www.newscom.com/cgi-bin/prnh/20080514...nd related,publications, since he joined the compa...
...New Rochelle, NY, May 14, 2008Environmental Justic... by Mary Ann Liebert, Inc. ( www.liebertpub.com ),...d discussion of the equitable treatment and involv... laws, regulations, and policies. The premier issu...
... PETERSBURG, Fla., May 14 This month, HealthFocus...ing and applying consumer,health and wellness know...,Study. This ongoing study of over 2000 shoppers p...sting possibilities,for the role of diet and nutri...
...ANN ARBOR, Mich.---Race is not a factor in the fir...sing records had somewhat longer tenures before be...losses than wins, a new study shows. , The Unive...ound no difference in "technical efficiency" by ra...
Other Medicine News:Health News:Las Vegas Plastic Surgeons First in U.S. to Offer LipoLite 2Health News:Pollution Particles Impair Blood Vessel Function 2Health News:AlphaMed Press Names George Kendall Vice President, Operations and Business Development 2Health News:Premier issue of Environmental Justice just published 2Health News:Premier issue of Environmental Justice just published 3Health News:For Shoppers, Nutrition has a Role in Treating Illness 2Health News:Racism not an issue in firing of NBA coaches 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: